All In Biotech

Free tool

FAERS Monitor: Procardia Xl

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019684 or its brand name (Procardia Xl, Nifedipine). Reports on generic versions are filed under their own applications.

Reports

47,621

Serious

36,714

77% of reports

Hospitalization

19,502

Death reported

5,300

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,641
  • dyspnoea2,507
  • fatigue2,421
  • diarrhoea2,388
  • nausea2,320
  • off label use2,171
  • headache2,101
  • dizziness1,846
  • hypertension1,835
  • pain1,739
  • death1,565
  • asthenia1,539
  • pneumonia1,538
  • acute kidney injury1,514
  • hypotension1,493

Reports by year received

View as table
YearReports
2004951
20051,016
20061,021
2007777
2008937
20091,038
20101,287
20111,445
20121,576
20131,306
20141,727
20152,093
20162,537
20172,782
20183,241
20193,663
20203,286
20213,017
20222,926
20232,986
20243,075
20252,834
20262,094

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,006,538 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal1,5144.44.23,968
hypertensionSignal1,8353.93.73,876
hypotensionSignal1,4933.33.12,402
pneumoniaSignal1,5382.12.0899
dyspnoea2,5072.01.91,206
asthenia1,5391.81.7566
dizziness1,8461.61.6466
diarrhoea2,3881.61.6607
headache2,1011.51.4337
fatigue2,4211.41.3255
nausea2,3201.31.2162
pain1,7391.31.290
off label use2,1711.11.119
drug ineffective2,6410.90.942
death1,5650.80.879

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.